<DOC>
<DOCNO>EP-0611571</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Teicoplanin containing topical compositions with delayed release of the active agent
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K39395	A61K900	A61K900	A61K39395	A61K3814	A61K3814	A61K3839	A61L2600	A61K3839	A61L2600	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61L	A61K	A61L	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K39	A61K9	A61K9	A61K39	A61K38	A61K38	A61K38	A61L26	A61K38	A61L26	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Delayed-release pharmaceutical composition which can be administered topically in the form of a dry product or of a suspension thereof in an inert liquid vehicle containing as sparingly water-soluble product the combination of     A) teicoplanin with B) at least one other pharmaceutical agent with, as a rule, basic characteristics.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MELZER WOLFGANG
</APPLICANT-NAME>
<APPLICANT-NAME>
MELZER, WOLFGANG DR.
</APPLICANT-NAME>
</APPLICANTS>
<CLAIMS>
Locally administrable medicament with delayed release in the form of a dry product
or a suspension thereof in an inert liquid excipient, containing the combination of


A) teicoplanin with
B) at least one further medicament active ingredient having basic character
as a product which is difficult to dissolve in water.
Medicament according to claim 1, characterised in that it contains components A)
to B) in the ratio from 1:8 to 8:1 in weight units.
Medicament according to one of the preceding claims, characterised in that
component B) is an antibiotic.
Medicament according to claim 3, characterised in that the antibiotic is an
aminoglycoside.
Medicament according to claim 4, characterised in that the aminoglcoside is
gentamicin, netilmicin or tobramycin.
Medicament according to one of claims 1 to 2, characterised in that component B)
is a protein based therapeutic preparation.
Medicament according to claim 6, characterised in that the protein is collagen or an
immunoglobulin, or belongs to the fibrin adhesive system.
Medicament according to claim 7, characterised in that component B) is collagen
in the form of a sponge or a nonwoven.
Medicament according to claim 8, characterised in that further active ingredients
are introduced in the excipient system of teicoplanin with collagen in the form of a

sponge or nonwoven. 
Use of a dry product or a suspension thereof in an inert liquid excipient, containing
the combination of


A) teicoplanin with
B) at least one further medicament active ingredient having basic character

as a product which is difficult to dissolve in water to produce a locally
administrable medicament with delayed release.
</CLAIMS>
</TEXT>
</DOC>
